Cargando…
Synthetic Mucus Nanobarriers for Identification of Glycan-Dependent Primary Influenza A Infection Inhibitors
[Image: see text] Current drugs against the influenza A virus (IAV) act by inhibiting viral neuraminidase (NA) enzymes responsible for the release of budding virions from sialoglycans on infected cells. Here, we describe an approach focused on a search for inhibitors that reinforce the protective fu...
Autores principales: | Cohen, Miriam, Senaati, Hooman P., Fisher, Christopher J., Huang, Mia L., Gagneux, Pascal, Godula, Kamil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2016
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084083/ https://www.ncbi.nlm.nih.gov/pubmed/27800553 http://dx.doi.org/10.1021/acscentsci.6b00191 |
Ejemplares similares
-
Influenza A penetrates host mucus by cleaving sialic acids with neuraminidase
por: Cohen, Miriam, et al.
Publicado: (2013) -
Swelling-strengthening hydrogels by embedding with deformable nanobarriers
por: Wu, Feng, et al.
Publicado: (2020) -
On the structure and oxygen transmission rate of biodegradable cellulose nanobarriers
por: Chinga-Carrasco, Gary, et al.
Publicado: (2012) -
Density Variant Glycan
Microarray for Evaluating Cross-Linking
of Mucin-like Glycoconjugates by Lectins
por: Godula, Kamil, et al.
Publicado: (2012) -
Identification of Novel Glycans in the Mucus Layer of Shark and Skate Skin
por: Bachar-Wikstrom, Etty, et al.
Publicado: (2023)